首页> 外文期刊>Circulation. Arrhythmia and electrophysiology >Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
【24h】

Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.

机译:心律失常性右室发育不良/心肌病中的室性心律失常的消融:基于心内膜基质的标测和消融后无心律失常的生存。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy, freedom from ventricular arrhythmias (VAs) after endocardial ablation is limited. We compared the long-term freedom from recurrent VAs by using endocardial-alone ablation versus endo-epicardial substrate-based ablation. METHODS AND RESULTS: Forty-nine patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing ablation of ventricular tachycardia (VT) were divided into 2 groups: endocardial-alone ablation (group 1, n = 23) and endo-epicardial ablation (group 2, n = 26). All patients had an implantable cardioverter-defibrillator (ICD). Conventional and 3D mappings were used to determine the mechanism of induced VTs and to identify area of "scar" or abnormal abnormal from both endocardium and epicardium (group 2). The procedural end point was noninducibility of sustained, monomorphic VT with isoproterenol. The presence of frequent premature ventricular contractions at the end of ablation was recorded. Patients were followed up by ECG, Holter, and ICD interrogation. After a follow-up of at least 3 years, freedom from VAs or ICD therapy was 52.2% (12/23) in group 1 and 84.6% (22/26) in group 2 (P = 0.029), with 21.7% (5/23) and 69.2% (18/26) patients off antiarrhythmic drugs (P < 0.001), respectively. Compared with patients with no premature ventricular contractions after ablation, patients with frequent premature ventricular contractions after ablation were more likely to have VA recurrence/ICD therapy [3/33 (9%) versus 12/16 (75%); log-rank P<0.001]. CONCLUSIONS: An endo-epicardial-based ablation strategy achieves higher long-term freedom from recurrent VAs off antiarrhythmic therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy when compared with endocardial-alone ablation. The presence of >/= 10 premature ventricular contractions per minute after ablation is associated with more VA recurrence.
机译:背景:患有心律失常的右室发育不良/心肌病的患者,心内膜消融后摆脱室性心律不齐(VA)的机会有限。我们比较了单独使用心内膜消融术与基于心外膜基底膜消融术对长期VA免于复发性VA的比较。方法和结果:49例发生心律失常性右室发育异常/心肌病的室速消融患者分为2组:单纯心内膜消融术(第1组,n = 23)和心内膜消融术(第2组,第2组)。 n = 26)。所有患者都有植入式心脏复律除颤器(ICD)。使用常规和3D映射来确定诱发室速的机制,并从心内膜和心外膜(组2)中识别“瘢痕”或异常异常的区域。手术的终点是用异丙肾上腺素不能诱导持续的单形性室速。记录消融结束时出现频繁的室性早搏。对患者进行心电图,动态心电图和ICD询问。随访至少3年后,第1组的VA或ICD治疗的自由度为52.2%(12/23),第2组的为84.6%(22/26)(P = 0.029),21.7%(5 / 23)和69.2%(18/26)停用抗心律失常药物的患者(P <0.001)。与消融后无早搏室收缩的患者相比,消融后有频繁早搏室收缩的患者更有可能接受VA复发/ ICD治疗[3/33(9%)vs 12/16(75%);对数秩P <0.001]。结论:与心内膜单纯消融相比,心律失常性右心室发育不良/心肌病患者采用心内膜外消融策略可从抗心律不齐疗法中获得长期免于VA的长期自由。消融后每分钟> / = 10个室性早搏的出现与更多的VA复发相关。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号